219 related articles for article (PubMed ID: 25275137)
21. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
22. Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.
Punjabi AS; Carroll PA; Chen L; Lagunoff M
J Virol; 2007 Mar; 81(5):2449-58. PubMed ID: 17151100
[TBL] [Abstract][Full Text] [Related]
23. An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.
Dubich T; Lieske A; Santag S; Beauclair G; Rückert J; Herrmann J; Gorges J; Büsche G; Kazmaier U; Hauser H; Stadler M; Schulz TF; Wirth D
J Mol Med (Berl); 2019 Mar; 97(3):311-324. PubMed ID: 30610257
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications.
Sivakumar R; Sharma-Walia N; Raghu H; Veettil MV; Sadagopan S; Bottero V; Varga L; Levine R; Chandran B
J Virol; 2008 Feb; 82(4):1759-76. PubMed ID: 18057235
[TBL] [Abstract][Full Text] [Related]
25. KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes.
Dimaio TA; Lagunoff M
Front Microbiol; 2012; 3():102. PubMed ID: 22479258
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus vFLIP promotes MEndT to generate hybrid M/E state for tumorigenesis.
Chen W; Ding Y; Liu D; Lu Z; Wang Y; Yuan Y
PLoS Pathog; 2021 Dec; 17(12):e1009600. PubMed ID: 34936683
[TBL] [Abstract][Full Text] [Related]
27. Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming.
Cancian L; Hansen A; Boshoff C
Trends Cell Biol; 2013 Sep; 23(9):421-32. PubMed ID: 23685018
[TBL] [Abstract][Full Text] [Related]
28. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
29. Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival.
Sanchez EL; Carroll PA; Thalhofer AB; Lagunoff M
PLoS Pathog; 2015 Jul; 11(7):e1005052. PubMed ID: 26197457
[TBL] [Abstract][Full Text] [Related]
30. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.
Guo Y; Li W; Qin J; Lu C; Fan W
J Med Virol; 2017 Jul; 89(7):1274-1280. PubMed ID: 28165144
[TBL] [Abstract][Full Text] [Related]
32. A role for virally induced reactive oxygen species in Kaposi's sarcoma herpesvirus tumorigenesis.
Ma Q; Cavallin LE; Leung HJ; Chiozzini C; Goldschmidt-Clermont PJ; Mesri EA
Antioxid Redox Signal; 2013 Jan; 18(1):80-90. PubMed ID: 22746102
[TBL] [Abstract][Full Text] [Related]
33. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
34. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1.
Ye FC; Blackbourn DJ; Mengel M; Xie JP; Qian LW; Greene W; Yeh IT; Graham D; Gao SJ
J Virol; 2007 Apr; 81(8):3980-91. PubMed ID: 17287278
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus infection of human bone-marrow-derived mesenchymal stem cells and their angiogenic potential.
Yoo SM; Jang J; Yoo C; Lee MS
Arch Virol; 2014 Sep; 159(9):2377-86. PubMed ID: 24777829
[TBL] [Abstract][Full Text] [Related]
39. Manipulation of endothelial cells by KSHV: implications for angiogenesis and aberrant vascular differentiation.
Ojala PM; Schulz TF
Semin Cancer Biol; 2014 Jun; 26():69-77. PubMed ID: 24486643
[TBL] [Abstract][Full Text] [Related]
40. Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.
An FQ; Folarin HM; Compitello N; Roth J; Gerson SL; McCrae KR; Fakhari FD; Dittmer DP; Renne R
J Virol; 2006 May; 80(10):4833-46. PubMed ID: 16641275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
